Table 1.
ETI (AvrRpt2 expression by Dex treatment) | PTI (flg22 treatment) | CPKs or MAPKs phosphorylation motif | |||||
---|---|---|---|---|---|---|---|
Ratio Dex 3 h / 0 h in Dex:avrRpt2 | Ratio Dex 3 h / 0 h in rpm1rps2/Dex:avrRpt2 | Ratio flg22/mock | |||||
Phosphorylation | Protein level | Phosphorylation | Protein level | Phosphorylation | |||
RBOHD (AT5G47910) | S163 | 10.97 | 3.32 | 1.39 | 1.28 | 3.72*1 | |
S343 | 13.08 | 0.83 | 4.7*1, 20.69*2, 4 | ||||
S347 | 13.83 | 0.94 | 3.5*1, 20.69*2, 4 | φ-X-X-X-X-S/T-X-B*7 | |||
PEN3 (AT1G59870) | S40 | 6.87 | 1.44 | 0.86 | 0.98 | 8.21*2 | φ-X-X-X-X-S/T-X-B*7 |
S45 | 27.23*5, 12.85*6 | 0.18*5, 1.34*6 | 4.66*2 | ||||
ACA8 (AT5G57110) | S22 | 20.80 | 1.50 | 2.48 | 0.68 | 3.74*2 | φ-X-X-X-X-S/T-X-B*7 |
XLG2 (AT4G34390) | S23 | 13.23 | nd | 0.32 | nd | Not quantified*3 | |
S169 | 3.02 | 0.20 | Not quantified*3 | ||||
CBS domain-containing protein (AT4G33700) | S331 | 5.65 | 1.11 | 1.07 | 0.66 | 1.8*1 | |
T336 | 5.96 | 0.70 | 2.9*1 | S/T-P*8 | |||
PEARLI 4 (AT2G16900) | S63 | 9.95 | nd | 1.33 | nd | 4.2*1 | S/T-P*8 |
AHA1 (AT2G18960) | T948 | 0.10 | 1.06 | 0.78 | 0.90 | 0.33*2 | |
AHA2 (AT4G30190) | T947 | 0.22 | 1.07 | 0.97 | 0.92 | 0.42*2 | |
AHA3 (AT5G57350) | T882 | 0.22 | nd | 0.60 | nd | 0.38*2 |
ETI, effector-triggered immunity; PTI, PAMP-triggered immunity.
Phosphorylation data after flg22 treatment is extracted from the papers indicated. The data are shown as fold change. For the data of RPS2, the fold change of the phosphorylated sites are calculated based on raw intensities. The fold change of the protein levels is calculated based on the Maxquant label-free quantitation intensities transformed to raw intensities (see Methods S1). Significantly differentially phosphorylated sites with a ratio higher than 1.5 or lower than 0.5 were kept, see also Tables S1–S3.
The phosphorylation ratio at 10 min after flg22 treatment (Benschop et al., 2007)
The best phosphorylation ratio at 7 min after flg22 treatment out of 5 reps is shown (Nühse et al., 2007).
Phosphorylated but not quantified (Liang et al., 2016)
Double phosphorylated peptide
Calculated based on singly phosphorylated phosphopeptide intensities (Table S1 Multiplicity = __1)
Calculated based on doubly phosphorylated phosphopeptide intensities (Table S1 Multiplicity = __2)
nd, not detected
CPK phosphorylation motif: φ-X-X-X-X-S/T-X-B (S/T is the phosphorylated residue, B is a basic residue, φ is a hydrophobic residue, X is any residue) (Huang et al., 2001; Huang & Huber, 2001; Hernandez Sebastia et al., 2004)
MAPK phosphorylation motif S/T-P (S/T is the phosphorylated residue)